Natera share price logo

Natera

NASDAQ: NTRA

Large Cap

$338.70

+0.25

(+0.07%)

as on

Natera Stock Performance

as on August 28, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $336.02
    $343.18
    downward going graph

    0.79%

    Downside

    1.32%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $157.43
    $343.18
    downward going graph

    53.52%

    Downside

    1.32%

    Upside

    downward going graph

Natera share price movements today

Previous Close
$338.45
Open
$337.96
Volume
447.0K
Market Cap
$48.8B
Day's Low - High
$336.02 - $343.18
52 Week Low - High
$157.43 - $343.18

Natera Historical Returns

1 Month Return
+ 34.29 %
3 Month Return
+ 58.32 %
1 Year Return
+ 101.75 %
3 Year Return
+ 510.16 %
5 Year Return
+ 187.11 %

Natera Stock Fundamentals & Key Indicators

Check Natera market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$48.8B

EPS (TTM)

-1.36

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-228.51

Industry PE ratio

5.3773333333333335

PEG Ratio

-14.076340270382525

EBITDA

-179.1M

Revenue (TTM)

2.7B

Profit Margin

65.30%

Return On Equity TTM

-11.73%

Natera Stock Valuation

Track how Natera P/E has moved over time to understand its valuation trends.

Natera in the last 5 years

  • Overview

  • Trends

Lowest (-150.72x)

December 31, 2025

Today (-150.72x)

December 31, 2025

Industry (5.38x)

December 31, 2025

Highest (-7.22x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -150.72x

Natera vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Natera with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Natera image
Natera
BUY$48.8B187.11%-228.5165.30%NA
Agilent image
Agilent
BUY$43.3B-9.27%31.0819.55%52.81%
Thermo Fisher image
Thermo Fisher
BUY$232.3B14.98%3240.37%0.3%
Danaher image
Danaher
BUY$151.8B-32.41%38.2258.51%0.67%

Stock Returns calculator for Natera Stock including INR - Dollar returns

The Natera stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Natera investment value today

Current value as on today

₹2,19,862

Returns

₹1,19,862

(+119.86%)

Returns from Natera Stock

₹1,01,751 (+101.75%)

Dollar Impact

₹18,110 (+18.11%)

Analyst Recommendation on Natera Stock

Based on 21 analysts

BUY

90.48%

Buy

9.52%

Hold

0.00%

Sell

Based on 21 analysts, 90.47619047619048% of analysts recommend a 'BUY' rating for Natera. Average target price of $336.74

Natera Share Price Target

Get share price movements and forecasts by analysts on Natera.

What analysts predicted

-0.58%DOWNSIDE

Target Price

$336.74

Current Price

$338.7

Analyzed by

21 Analysts

Target

$336.74

Natera target price $336.74, a slight downside of -0.58% compared to current price of $338.7. According to 21 analysts rating.

Indian Investors' Interest in Natera Stock

Investment in Natera Shares on INDmoney has dropped by -48.97% in the last 30 days, indicating reduced investment activity.

Time period: to

Change:-48.97% versus previous 30 day period

Search interest for Natera Stock has decreased by -16% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-16% versus previous 30 day period

Natera Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
367
413
439
476
501
546
592
665
696
752
Gross Profit
208
243
271
299
317
347
384
446
451
485
Operating Income
-74
-43
-39
-64
-79
-110
-97
-22
-93
-75
EBITDA
-53
-25
-19
-46
-56
-89
-76
7
-65
-45
Interest Expense
3
3
3
1
1
1
1
7
0
0
Depreciation
10
7
8
7
9
9
9
14
20
21
Income Before Tax
-67
-36
-30
-55
-66
-100
-87
-13
-84
-67
Income Tax Expense
0
0
0
-1
0
0
0
-60
0
0
Net Income
-67
-37
-31
-53
-66
-100
-87
47
-85
-66
Net Profit Margin
56.72%
58.83%
61.79%
62.94%
63.21%
63.50%
64.91%
67.14%
64.80%
64.46%

Natera Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
210
257
302
391
625
820
1,082
1,696
2,306
Gross Profit
71
91
126
187
307
363
492
1,023
1,495
Operating Income
-134
-114
-116
-216
-468
-541
-446
-222
-309
EBITDA
-125
-107
-104
-205
-451
-507
-383
-148
-220
Interest Expense
4
10
10
15
8
9
12
10
4
Depreciation
7
7
7
8
11
30
38
30
43
Income Before Tax
-135
-127
-122
-229
-471
-546
-434
-189
-268
Income Tax Expense
0
0
1
0
0
0
0
0
-59
Net Income
-136
-128
-124
-229
-471
-547
-434
-190
-208
Net Profit Margin
33.82%
35.55%
41.96%
47.92%
49.09%
44.37%
45.52%
60.30%
64.85%

Natera Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-67
-37
-31
-53
-66
-100
-87
47
-85
-66
Operating Cash Flow
27
3
51
52
44
37
59
73
40
54
Investing Cash Flow
138
-32
42
-11
-16
-23
-19
-71
-32
-63
Financing Cash Flow
6
11
1
10
0
12
1
32
3
12
Change in Cash
171
-17
96
52
28
26
41
34
11
3

Natera Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-137
-128
-124
-229
-471
-547
-434
-190
-208
Operating Cash Flow
-96
-70
-63
-182
-335
-431
-246
135
215
Investing Cash Flow
13
-5
-266
-331
-205
330
168
137
-132
Financing Cash Flow
80
113
340
500
576
482
254
30
47
Change in Cash
-3
37
10
-13
35
381
176
303
130

Mutual Funds that own Natera Stock

Check out the Mutual Funds with significant holdings in Natera.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
7.297013%
10518219
JPMorgan Trust II
4.768654%
6873738
Franklin Custodian Funds
1.005937%
1450000
MFS Series Trust IV
0.983198%
1417224
Fidelity Concord Street Trust
0.967756%
1394965
See all

Global Institutional Holdings in Natera

Funds
Holdings
Vanguard
8.24%
iShares
3.29%
Stanley Druckenmiller
2.21%
Philippe Laffont
1.74%
Andrew J.M. Spokes
1.54%
See all

Natera News & Key Events

    Insights on Natera

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Profit Spike

      img

      Natera, Inc. has seen an improvement in its net profit over the last two quarters. The net profit increased from -85.09 million dollars to -66.96 million dollars, reflecting an average increase of 27.1% each quarter.

    • imgPOSITIVE IMPACT

      Revenue Rich

      img

      Natera, Inc. Common Stock has shown strong revenue growth, with revenue increasing for the last 21 quarters. It has risen from $142.02 million to $752.75 million, marking an average quarterly increase of 7.9%. This consistent revenue growth indicates positive performance for the company over a significant period.

    • imgPOSITIVE IMPACT

      Best in 1 Year

      img

      In the last 1 year, NTRA has outperformed top 5 stocks with highest market-cap in its industry

    • imgPOSITIVE IMPACT

      Price Rise

      img

      In the last 1 month, NTRA stock has moved up by 34.3%

    • imgPOSITIVE IMPACT

      Best in 3 Years

      img

      In the last 3 years, NTRA has outperformed top 5 stocks with highest market-cap in its industry

    About Natera

    Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehensive genomic profiling test; and Empower, a hereditary cancer screening test. The company also provides Panorama, a non-invasive prenatal test; Horizon, a carrier screening test; Fetal Focus, a single-gene NIPT, or sgNIPT, that screens for 21 single-gene inherited conditions; and Vistara, a single-gene NIPT, which screens for 25 single-gene conditions. In addition, it offers Anora, which tests and analyzes miscarriage tissue from women who have experienced one or more pregnancy losses; Empower, a hereditary cancer screening test; Prospera, a test to assess active rejection in patients who have undergone solid organ transplantation; Renasight, a kidney gene panel test; and Constellation software, a cloud-based distribution model. Further, the company provides NateraCore, a platform to support the patient and provider experience; phlebotomy services; and EMR integration services. The company serves independent laboratories, national and regional reference laboratories, medical centers and physician practices for its screening tests, research laboratories, and pharmaceutical companies through its direct sales force and laboratory distribution partners, as well as Constellation licensees under its cloud-based distribution model. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays for clinical and commercial use. The company has a collaboration with Diakonos Oncology Corp. to assess molecular response in patients with refractory melanoma. The company was formerly known as Gene Security Network, LLC and changed its name to Natera, Inc. in Januar
    OrganisationNatera
    Headquarters13011 McCallen Pass, Austin, TX, United States, 78753
    IndustryDiagnostics & Research
    CEOMr. Steven Leonard Chapman
    E-voting on sharesClick here to vote

    Key Management of Natera

    Name

    Title

    Dr. Matthew Rabinowitz Ph.D.

    Co-Founder & Executive Chairman

    Mr. John Fesko

    President & Chief Business Officer

    Mr. Michael B. Brophy M.B.A.

    Chief Financial Officer

    Mr. Jonathan Sheena M.Eng.

    Co-Founder & Director

    Mr. Eric A. Evans Ph.D.

    Chief Scientific Officer

    Mr. Daniel Rabinowitz L.L.M.

    Secretary & Chief Legal Officer

    Mr. Steven Leonard Chapman

    CEO & Director

    Mr. Solomon Moshkevich M.B.A.

    President of Clinical Diagnostics

    Ms. Olesya A. Anisimova CPA

    Chief Accounting Officer

    Mr. Rishi Kacker

    Chief Technology Officer

    FAQs

    What is Natera share price today?

    Natera share price today is $338.70 as on at the close of the market. Natera share today touched a day high of $343.18 and a low of $336.02.

    What is the 52 week high and 52 week low for Natera share?

    Natera share touched a 52 week high of $343.18 on and a 52 week low of $157.43 on . Natera stock price today i.e. is closed at $338.70,which is 1.31% down from its 52 week high and 115.15% up from its 52 week low.

    What is Natera's market capitalisation today?

    Natera market capitalisation is $0.05T as on .

    How to invest in Natera Stock (NTRA) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Natera on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Natera Shares that will get you 0.0044 shares as per Natera share price of $338.70 per share as on August 28, 2026 at 8:46 am IST.

    What is the minimum amount required to buy Natera Stock (NTRA) from India?

    Indian investors can start investing in Natera (NTRA) shares with as little as ₹95.53 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹955.30 in Natera stock (as per the Rupee-Dollar exchange rate as on ). Based on Natera share’s latest price of $338.70 as on August 28, 2026 at 8:46 am IST, you will get 0.0295 shares of Natera. Learn more about fractional shares .

    What are the returns that Natera has given to Indian investors in the last 5 years?

    Natera stock has given 187.11% share price returns and 30.32% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?